Creatinine Measurement Market to reach reach 564.5 Million $ by 2023

The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 377.2 Million in 2018, at a CAGR of 8.4%.

(EMAILWIRE.COM, August 03, 2018 ) Full Report : https://www.marketsandmarkets.com/Market-Reports/creatinine-measurement-market-206847385.html  The objectives of this study are as follows:

To define, describe, and forecast the global creatinine measurement on the basis of type, type of sample, end user, product and region
To estimate the total number of creatinine measurement tests conducted by type and region.
To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders
To forecast the size of the market with respect to five regions: North America, Europe, Asia, and the Rest of the World (RoW)
To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
To track and analyze competitive developments in the creatinine measurement market, such as acquisitions, agreements, product launches & upgrades, expansions, and R&D activities
Press Release : https://www.marketsandmarkets.com/PressReleases/creatinine-measurement.asp 

Research Methodology

The study estimates the creatinine measurement market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include physicians/doctors, healthcare professionals, clinical laboratory executives, lab managers, laboratory assistants, and biochemistry consultants.

For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the creatinine measurement market as well as to estimate the market size of various other dependent submarkets.

All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Secondary sources such as directories; databases such as D&B Hoovers, Bloomberg Business, and Factiva; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies were referred.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=206847385

Based on the type of sample, the blood/serum segment is expected to register the highest CAGR during the forecast period

Based on type of sample the creatinine measurement market is segmented into blood/serum and urine samples. The blood/serum segment is expected to witness the highest CAGR over the forecast period. Most creatinine measurement kits and reagents are based on the analysis of creatinine in blood samples owing to its accuracy in inferring creatinine concentration and low risk of contamination. These benefits are responsible for the increasing adoption of the blood/serum sample for the measurement of creatinine levels.

North America to dominate the creatinine measurement market

In 2018, North America is expected to dominate the market followed by Europe. The large share of North America is attributed to factors such as the increasing incidence of renal disorders, rising prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction) in the region, and the implementation of favorable government initiatives to increase awareness about kidney diseases and their early diagnosis.

The creatinine measurement market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include F. Hoffmann-la Roche Ltd (Switzerland)., Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific Inc (US), Siemens Healthineers (Germany), Randox Laboratories (UK)., Pointe Scientific, Inc (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories, Inc (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).